362 related articles for article (PubMed ID: 32655769)
1. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
Martis RM; Knight LJ; Donaldson PJ; Lim JC
Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the cystine-glutamate exchanger in the mouse eye: a role for xCT in controlling extracellular redox balance.
Martis RM; Donaldson PJ; Li B; Middleditch M; Kallingappa PK; Lim JC
Histochem Cell Biol; 2019 Oct; 152(4):293-310. PubMed ID: 31396687
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for redox control by the human cystine/glutamate antiporter system xc
Parker JL; Deme JC; Kolokouris D; Kuteyi G; Biggin PC; Lea SM; Newstead S
Nat Commun; 2021 Dec; 12(1):7147. PubMed ID: 34880232
[TBL] [Abstract][Full Text] [Related]
4. Early Onset of Age-Related Cataracts in Cystine/Glutamate Antiporter Knockout Mice.
Martis RM; Li B; Donaldson PJ; Lim JC
Invest Ophthalmol Vis Sci; 2021 Jun; 62(7):23. PubMed ID: 34156426
[TBL] [Abstract][Full Text] [Related]
5. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
[TBL] [Abstract][Full Text] [Related]
6. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-) : cystine supplier and beyond.
Conrad M; Sato H
Amino Acids; 2012 Jan; 42(1):231-46. PubMed ID: 21409388
[TBL] [Abstract][Full Text] [Related]
7. Effect of oxidative stress on cystine transportation by xC‾ antiporter.
Ghasemitarei M; Yusupov M; Razzokov J; Shokri B; Bogaerts A
Arch Biochem Biophys; 2019 Oct; 674():108114. PubMed ID: 31557465
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target.
Albrecht P; Lewerenz J; Dittmer S; Noack R; Maher P; Methner A
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):373-82. PubMed ID: 20053169
[TBL] [Abstract][Full Text] [Related]
9. Transport of cystine across xC
Ghasemitarei M; Yusupov M; Razzokov J; Shokri B; Bogaerts A
Arch Biochem Biophys; 2019 Mar; 664():117-126. PubMed ID: 30738038
[TBL] [Abstract][Full Text] [Related]
10. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.
Lewerenz J; Hewett SJ; Huang Y; Lambros M; Gout PW; Kalivas PW; Massie A; Smolders I; Methner A; Pergande M; Smith SB; Ganapathy V; Maher P
Antioxid Redox Signal; 2013 Feb; 18(5):522-55. PubMed ID: 22667998
[TBL] [Abstract][Full Text] [Related]
11. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity.
Lewerenz J; Klein M; Methner A
J Neurochem; 2006 Aug; 98(3):916-25. PubMed ID: 16771835
[TBL] [Abstract][Full Text] [Related]
12. Glutamate, excitatory amino acid transporters, Xc- antiporter, glutamine synthetase, and gamma-glutamyltranspeptidase in human corneal epithelium.
Langford MP; Redmond P; Chanis R; Misra RP; Redens TB
Curr Eye Res; 2010 Mar; 35(3):202-11. PubMed ID: 20373878
[TBL] [Abstract][Full Text] [Related]
13. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?
Savaskan NE; Hahnen E; Eyüpoglu IY
J Cell Physiol; 2009 Aug; 220(2):531-2; author reply 533-4. PubMed ID: 19415694
[No Abstract] [Full Text] [Related]
14. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
15. Glial Glutamate Transporter-Mediated Plasticity: System x
Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
Pampliega O; Domercq M; Soria FN; Villoslada P; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2011 Jun; 8():63. PubMed ID: 21639880
[TBL] [Abstract][Full Text] [Related]
17. Cystine/glutamate transporter, system x
Kobayashi S; Hamashima S; Homma T; Sato M; Kusumi R; Bannai S; Fujii J; Sato H
Nitric Oxide; 2018 Aug; 78():32-40. PubMed ID: 29792932
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
19. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
Uno K; Takarada T; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Pharmacol Sci; 2011; 115(3):309-19. PubMed ID: 21325781
[TBL] [Abstract][Full Text] [Related]
20. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
